Terms: = Bone cancer AND MEN1, ENSG00000133895, 4221 AND Treatment
16 results:
1. Current understanding of pathogenetic mechanisms in neuroendocrine neoplasms.
Modica R; Liccardi A; Minotta R; Cannavale G; Benevento E; Colao A
Expert Rev Endocrinol Metab; 2024; 19(1):49-61. PubMed ID: 37936421
[TBL] [Abstract] [Full Text] [Related]
2. Genomic Profiling Reveals the Variant Landscape of Sporadic Parathyroid Adenomas in Chinese Population.
Tao X; Xu T; Lin X; Xu S; Fan Y; Guo B; Deng X; Jiao Q; Chen L; Wei Z; Chen C; Yang W; Zhang Z; Yu X; Yue H
J Clin Endocrinol Metab; 2023 Jun; 108(7):1768-1775. PubMed ID: 36611251
[TBL] [Abstract] [Full Text] [Related]
3. treatment Response and Clinical Outcomes of Well-Differentiated High-Grade Neuroendocrine Tumors to Lutetium-177-DOTATATE.
Raj N; Coffman K; Le T; Do RKG; Rafailov J; Choi Y; Chou JF; Capanu M; Dunphy M; Fox JJ; Grewal RK; Reddy RP; Riedl C; Schoder H; Bodei L; Reidy-Lagunes D
Neuroendocrinology; 2022; 112(12):1177-1186. PubMed ID: 35609558
[TBL] [Abstract] [Full Text] [Related]
4. [Sporadic primary hyperparathyroidism with multiple parathyroid adenomas].
Bibik EE; Eremkina AK; Knyazeva OA; Mokrysheva NG
Probl Endokrinol (Mosk); 2021 Nov; 67(6):31-38. PubMed ID: 35018759
[TBL] [Abstract] [Full Text] [Related]
5. Concomitant familial hypocalciuric hypercalcemia and single parathyroid adenoma: a case report.
Marstrand SD; Tofteng CL; Jarløv A; Borgwardt L; Schwarz P
J Med Case Rep; 2021 Sep; 15(1):471. PubMed ID: 34556169
[TBL] [Abstract] [Full Text] [Related]
6. Epigenetic-based targeted therapies for well-differentiated pancreatic neuroendocrine tumors: recent advances and future perspectives.
Marini F; Giusti F; Brandi ML
Expert Rev Endocrinol Metab; 2021 Nov; 16(6):295-307. PubMed ID: 34554891
[TBL] [Abstract] [Full Text] [Related]
7. Acromegaly and non-parathyroid hormone-dependent hypercalcemia: a case report and literature review.
Shi S; Zhang L; Yu Y; Wang C; Li J
BMC Endocr Disord; 2021 May; 21(1):90. PubMed ID: 33933067
[TBL] [Abstract] [Full Text] [Related]
8. Pituitary adenomas in the setting of multiple endocrine neoplasia type 1: a single-institution experience.
Cohen-Cohen S; Brown DA; Himes BT; Wheeler LP; Ruff MW; Major BT; Singh Ospina NM; Atkinson JLD; Meyer FB; Bancos I; Young WF; Van Gompel JJ
J Neurosurg; 2020 Apr; 134(3):1132-1138. PubMed ID: 32244213
[TBL] [Abstract] [Full Text] [Related]
9. [Primary hyperparathyroidism in Russia according to the registry].
Mokrysheva NG; Mirnaya SS; Dobreva EA; Maganeva IS; Kovaleva EV; Krupinova JA; Kryukova IV; Tevosyan LK; Lukyanov SV; Markina NV; Bondar IA; Podprugina NG; Ignatieva IA; Shabelnikova OY; Dreval AV; Antsiferov MB; Mel'nichenko GA; Dedov II
Probl Endokrinol (Mosk); 2019 Nov; 65(5):300-310. PubMed ID: 32202734
[TBL] [Abstract] [Full Text] [Related]
10. 18F-FDOPA Uptake Reflects the Efficacy of Dopamine Agonists treatment in Pituitary Prolactinoma.
Heimburger C; Bund C; Addeo P; Goichot B; Imperiale A
Clin Nucl Med; 2018 Sep; 43(9):e324-e325. PubMed ID: 30052596
[TBL] [Abstract] [Full Text] [Related]
11. Safety and Tolerability of Empagliflozin in Patients with Type 2 Diabetes: Pooled Analysis of Phase I-III Clinical Trials.
Kohler S; Zeller C; Iliev H; Kaspers S
Adv Ther; 2017 Jul; 34(7):1707-1726. PubMed ID: 28631216
[TBL] [Abstract] [Full Text] [Related]
12. Molecular and Clinical Aspects of the Target Therapy with the Calcimimetic Cinacalcet in the treatment of Parathyroid Tumors.
Mingione A; Verdelli C; Terranegra A; Soldati L; Corbetta S
Curr Cancer Drug Targets; 2015; 15(7):563-74. PubMed ID: 26033088
[TBL] [Abstract] [Full Text] [Related]
13. Effect of hormone therapy on long-term outcomes of patients with human epidermal growth factor receptor 2- and hormone receptor-positive metastatic breast cancer: real world experience in China.
Du F; Yuan P; Wang JY; Ma F; Fan Y; Luo Y; Xu BH
Asian Pac J Cancer Prev; 2015; 16(3):903-7. PubMed ID: 25735380
[TBL] [Abstract] [Full Text] [Related]
14. Long-term control of a men1 prolactin secreting pituitary carcinoma after temozolomide treatment.
Philippon M; Morange I; Barrie M; Barlier A; Taieb D; Dufour H; Conte-Devolx B; Brue T; Castinetti F
Ann Endocrinol (Paris); 2012 Jun; 73(3):225-9. PubMed ID: 22520146
[TBL] [Abstract] [Full Text] [Related]
15. Sinonasal smooth muscle cell tumors: a clinicopathologic and immunohistochemical analysis of 12 cases with emphasis on the low-grade end of the spectrum.
Huang HY; Antonescu CR
Arch Pathol Lab Med; 2003 Mar; 127(3):297-304. PubMed ID: 12653572
[TBL] [Abstract] [Full Text] [Related]
16. Prospective study of thymic carcinoids in patients with multiple endocrine neoplasia type 1.
Gibril F; Chen YJ; Schrump DS; Vortmeyer A; Zhuang Z; Lubensky IA; Reynolds JC; Louie A; Entsuah LK; Huang K; Asgharian B; Jensen RT
J Clin Endocrinol Metab; 2003 Mar; 88(3):1066-81. PubMed ID: 12629087
[TBL] [Abstract] [Full Text] [Related]
